ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/02/20 | 1,966 | 1,982 | 1,941 | 1,950 | -16 | -0.8% | 35,300 |
2020/02/19 | 1,979 | 1,983 | 1,960 | 1,966 | +4 | +0.2% | 43,300 |
2020/02/18 | 1,995 | 2,001 | 1,957 | 1,962 | -34 | -1.7% | 39,300 |
2020/02/17 | 2,016 | 2,016 | 1,989 | 1,996 | -28 | -1.4% | 27,800 |
2020/02/14 | 2,023 | 2,030 | 1,995 | 2,024 | +1 | ±0% | 41,400 |
2020/02/13 | 2,045 | 2,061 | 2,019 | 2,023 | -32 | -1.6% | 63,200 |
2020/02/12 | 2,082 | 2,091 | 2,053 | 2,055 | -29 | -1.4% | 29,400 |
2020/02/10 | 2,112 | 2,123 | 2,071 | 2,084 | -51 | -2.4% | 41,200 |
2020/02/07 | 2,119 | 2,140 | 2,106 | 2,135 | +1 | ±0% | 38,100 |
2020/02/06 | 2,090 | 2,154 | 2,081 | 2,134 | +64 | +3.1% | 118,300 |
2020/02/05 | 2,100 | 2,112 | 2,034 | 2,070 | +100 | +5.1% | 110,700 |
2020/02/04 | 1,930 | 1,979 | 1,930 | 1,970 | +55 | +2.9% | 64,300 |
2020/02/03 | 1,929 | 1,960 | 1,915 | 1,915 | -37 | -1.9% | 62,300 |
2020/01/31 | 1,947 | 1,975 | 1,947 | 1,952 | +5 | +0.3% | 50,400 |
2020/01/30 | 1,979 | 1,985 | 1,939 | 1,947 | -33 | -1.7% | 61,300 |
2020/01/29 | 1,970 | 1,986 | 1,967 | 1,980 | -6 | -0.3% | 61,400 |
2020/01/28 | 1,980 | 1,992 | 1,955 | 1,986 | -11 | -0.6% | 56,400 |
2020/01/27 | 2,007 | 2,019 | 1,980 | 1,997 | -50 | -2.4% | 81,300 |
2020/01/24 | 2,080 | 2,080 | 2,031 | 2,047 | -33 | -1.6% | 43,200 |
2020/01/23 | 2,073 | 2,105 | 2,071 | 2,080 | -2 | -0.1% | 53,300 |
2020/01/22 | 2,067 | 2,094 | 2,067 | 2,082 | +3 | +0.1% | 44,900 |
2020/01/21 | 2,052 | 2,081 | 2,044 | 2,079 | +3 | +0.1% | 42,000 |
2020/01/20 | 2,069 | 2,095 | 2,068 | 2,076 | +7 | +0.3% | 42,000 |
2020/01/17 | 2,078 | 2,088 | 2,053 | 2,069 | -9 | -0.4% | 33,400 |
2020/01/16 | 2,072 | 2,092 | 2,064 | 2,078 | +17 | +0.8% | 34,700 |
2020/01/15 | 2,070 | 2,079 | 2,053 | 2,061 | -17 | -0.8% | 32,700 |
2020/01/14 | 2,104 | 2,107 | 2,068 | 2,078 | -29 | -1.4% | 58,700 |
2020/01/10 | 2,094 | 2,119 | 2,094 | 2,107 | -1 | ±0% | 44,400 |
2020/01/09 | 2,104 | 2,115 | 2,089 | 2,108 | +37 | +1.8% | 40,900 |
2020/01/08 | 2,073 | 2,087 | 2,042 | 2,071 | -20 | -1% | 59,000 |
2020/01/07 | 2,061 | 2,101 | 2,061 | 2,091 | +55 | +2.7% | 61,000 |
2020/01/06 | 2,011 | 2,056 | 2,011 | 2,036 | -68 | -3.2% | 95,300 |
2019/12/30 | 2,131 | 2,131 | 2,101 | 2,104 | -33 | -1.5% | 46,100 |
2019/12/27 | 2,132 | 2,146 | 2,121 | 2,137 | +18 | +0.8% | 42,200 |
2019/12/26 | 2,111 | 2,121 | 2,088 | 2,119 | +15 | +0.7% | 43,300 |
2019/12/25 | 2,125 | 2,127 | 2,103 | 2,104 | -5 | -0.2% | 36,700 |
2019/12/24 | 2,100 | 2,127 | 2,100 | 2,109 | +23 | +1.1% | 41,500 |
2019/12/23 | 2,082 | 2,100 | 2,077 | 2,086 | +8 | +0.4% | 36,800 |
2019/12/20 | 2,098 | 2,105 | 2,073 | 2,078 | -27 | -1.3% | 77,900 |
2019/12/19 | 2,073 | 2,107 | 2,069 | 2,105 | +23 | +1.1% | 50,100 |
2019/12/18 | 2,122 | 2,122 | 2,074 | 2,082 | -34 | -1.6% | 58,700 |
2019/12/17 | 2,119 | 2,120 | 2,095 | 2,116 | +2 | +0.1% | 67,700 |
2019/12/16 | 2,124 | 2,124 | 2,109 | 2,114 | -9 | -0.4% | 34,500 |
2019/12/13 | 2,123 | 2,143 | 2,114 | 2,123 | +35 | +1.7% | 80,000 |
2019/12/12 | 2,100 | 2,115 | 2,088 | 2,088 | -36 | -1.7% | 51,700 |
2019/12/11 | 2,157 | 2,157 | 2,117 | 2,124 | -26 | -1.2% | 40,100 |
2019/12/10 | 2,182 | 2,190 | 2,147 | 2,150 | -22 | -1% | 41,100 |
2019/12/09 | 2,155 | 2,175 | 2,143 | 2,172 | +17 | +0.8% | 63,500 |
2019/12/06 | 2,144 | 2,165 | 2,140 | 2,155 | -17 | -0.8% | 47,500 |
2019/12/05 | 2,170 | 2,188 | 2,145 | 2,172 | +2 | +0.1% | 73,200 |
1351~
1400
件表示中 / 3771件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 203,600円 | +3.1% | -6.5% | 2.36% | 9.45倍 | 1.00倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ジーエヌアイ | 264,500円 | +21.7% | +999.9% | 0.00% | 12.19倍 | 4.17倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 314,500円 | +5.1% | -7.0% | 2.54% | 20.65倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
栄研化 | 247,000円 | +4.1% | -3.1% | 2.35% | 21.46倍 | 1.87倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
杏林製薬 | 152,000円 | -2.4% | -52.3% | 3.75% | 18.19倍 | 0.64倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム